Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Labiana HealthSTU:8RK +1.54%65 OCF Margin % is 6.24% as of Dec. 2025, which is 7% below its 10-year median of 6.71. GuruFocus rates STU:8RK with a GF Score™ of 65/100 and a GF Value™ of €3.25 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 964 Drug Manufacturers companies, Labiana Health ranks worse than 68.78% on this metric.
The historical rank and industry rank for Labiana Health's OCF Margin % or its related term are showing as below:
STU:8RK'
s OCF Margin % Range Over the Past 10 Years
Min: -3.12 Med: 6.71 Max: 10.85
Current: 2.26
During the past 6 years, the highest OCF Margin % of Labiana Health was 10.85%. The lowest was -3.12%. And the median was 6.71%.
STU:8RK's OCF Margin % is ranked worse than 68.78% of 964
companies
in the Drug Manufacturers industry
Industry Median: 10.04
vs STU:8RK: 2.26
Labiana Health OCF Margin % Related Terms
Labiana Health OCF Margin % Historical Data
* Premium members only.
The historical data trend for Labiana Health's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:8RK vs ZTS, UTHR, VTRS: OCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Labiana Health's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Labiana Health OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Labiana Health's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Labiana Health's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Labiana Health (STU:8RK) has a OCF Margin % of 6.24% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Labiana Health and its competitors. This is near median its historical median of 6.71. According to the industry distribution chart, Labiana Health ranks #663 out of 964 companies in the Drug Manufacturers industry, placing it in the top 68.8%.
Is Labiana Health's OCF Margin % too high?
Labiana Health's current OCF Margin % of 6.24% is near median its 10-year median of 6.71. The Drug Manufacturers industry median OCF Margin % is 10.04. Labiana Health's value of 6.24% is 37.8% below this industry median. Based on the distribution chart, Labiana Health ranks #663 out of 964 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Labiana Health has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Labiana Health's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Labiana Health ranks #663 out of 964 companies for OCF Margin %. This places Labiana Health in the lower half of its industry. The industry median OCF Margin % is 10.04. Labiana Health's value of 6.24% is 37.8% below this benchmark. While the company's 10-year median is 6.71 vs. the industry median of 10.04, Labiana Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 10.04, based on 964 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Labiana Health's current OCF Margin % of 6.24% is 37.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Labiana Health and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 10.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Labiana Health's current OCF Margin % is 6.24%, which is near median its own 10-year median of 6.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labiana Health stock overvalued right now?
Based on GuruFocus' analysis, Labiana Health (STU:8RK) is currently considered Significantly Overvalued. The stock's GF Value™ is €3.25, compared to a current price of €6.60 — trading 103.1% above its estimated fair value. The current OCF Margin % is 6.24%, which is near median its 10-year median of 6.71 and 37.8% below the Drug Manufacturers industry median of 10.04. Labiana Health's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Labiana Health (STU:8RK), the current OCF Margin % is 6.24% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Labiana Health (STU:8RK) Overvalued in 2026?
Based on GuruFocus' analysis, Labiana Health stock appears to be overvalued.
The current stock price of €6.60 is trading 103.1% above its estimated GF Value™ of €3.25.
GuruFocus considers Labiana Health to be Significantly Overvalued.
Key valuation signals for STU:8RK:
OCF Margin %: 6.24% (near median its 10-year median of 6.71)
GF Value™: €3.25 vs. price of €6.60 (103.1% above fair value)
Industry Position: 37.8% below the Drug Manufacturers median (#663 of 964)
No single metric tells the full story. See the STU:8RK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include a GMP manufacturer for EU animal and human health industries, a manufacturer specializing in sterile and lyophilized dosage forms, and a source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol. The company operates in two segment Animal Health and Human Health.
65GF Score
Get the complete analysis for STU:8RK
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:8RK has been successfully added to your 
